| John Joseph Lareau, RPH | |
|
2819 Majesty Ct, Norman, OK 73072-7529 | |
| (405) 273-5236 | |
| (405) 273-2392 |
| Full Name | John Joseph Lareau |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2819 Majesty Ct, Norman, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023050846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 7503 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Joseph Lareau, RPH 2819 Majesty Ct, Norman, OK 73072-7529 Ph: (405) 364-9512 | John Joseph Lareau, RPH 2819 Majesty Ct, Norman, OK 73072-7529 Ph: (405) 273-5236 |
News Archive
Siemens Healthcare has launched the new versatile and cost-effective Biograph Horizon PET/CT system, which offers premium performance at an attractive total cost of ownership.
Today, Boehringer Ingelheim has announced the submission of a Marketing Authorisation Application to the European Medicines Agency (EMA) for approval of afatinib, the first irreversible ErbB Family Blocker, as a treatment for patients with EGFR (ErbB1) mutation positive non-small cell lung cancer (NSCLC). Afatinib has demonstrated unprecedented efficacy versus chemotherapy in the Phase III LUX-Lung 3 registration trial, which provides pivotal support for this submission.
TherapeuticsMD, Inc., an innovative women's healthcare company, today announced that the United States Food and Drug Administration has approved BIJUVA (estradiol and progesterone) capsules, 1 mg/100 mg, the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms (commonly known as hot flashes or flushes) due to menopause in women with a uterus.
Patients who need a positron emission tomography (PET)/computed tomography (CT) procedure to evaluate known or suspected malignancies should lay off the java, according to research by Medhat M. Osman, M.D., Ph.D., assistant professor in the department of internal medicine's division of nuclear medicine and director of PET at Saint Louis University Hospital.
The European ME Alliance (EMEA) is calling on Europe's health ministers to initiate an immediate Europe-wide prohibition of blood donation from people who have been diagnosed with myalgic encephalomyelitis (ME/CFS).
› Verified 8 days ago
Shauna Beth Stinnett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Porter Ave Ste 101, Norman, OK 73071 Phone: 405-364-5222 Fax: 405-364-7076 | |
Ms. Danna Kaye Hutchinson, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 808 N Porter, Norman, OK 73071 Phone: 405-321-1445 Fax: 405-321-1446 | |
Dr. Michaela Metts, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 580-380-6367 | |
Justin Michael Walker, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2551 Classen Blvd, Norman, OK 73071 Phone: 405-515-7423 | |
Dr. Betsy S Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman Regional Hospital, Norman, OK 73071 Phone: 405-307-1950 | |
Dr. Veronica Scafe, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3651 W Robinson St, Norman, OK 73072 Phone: 405-360-5406 |